Table 4.
Treatment and Outcomes of Patients with Splenic Infarction at Diagnosis (n=15).
| Treatment | ||
| Initial cytoreduction, n, (%) | ||
| Hydroxyurea | 9 (60.0) | |
| Anagrelide | 0 (0.0) | |
| Ruxolitinib | 1 (6.7) | |
| None | 5 (33.3) | |
| Low-dose aspirin, n (%) | 12 (80.0) | |
| Analgesics, n (%) | ||
| NSAID | 2 (13.3) | |
| Narcotic agents | 6 (40.0) | |
| None | 7 (46.7) | |
| Surgical treatment, n (%) | 0 (0.0) | |
| Outcomes | ||
| Complications, n (%) | ||
| Abscess | 0 (0.0) | |
| Fistula | 0 (0.0) | |
| Peritonitis | 0 (0.0) | |
| Others | 0 (0.0) | |
| Radiologic resolution, n (%) | ||
| Residual non-perfused area* | 1/7 (14.3) | |
| No non-perfused area** | 6/7 (85.7) |
NSAID: non-steroidal anti-inflammatory drug
* Computed tomography performed at 23 months after diagnosis.
** Computed tomography performed at a median of 18 months (range: 9-80 months) after diagnosis.